Results for tag: "Autoimmune Disease Drug"

The Autoimmune Disease Drug market is a subset of the Immune Disorders Drugs market, which focuses on treatments for diseases caused by an overactive immune system. These drugs are used to reduce inflammation, suppress the immune system, and prevent the body from attacking its own tissues. Common autoimmune diseases include rheumatoid arthritis, psoriasis, lupus, and multiple sclerosis. Autoimmune Disease Drugs are typically divided into two categories: biologics and small molecules. Biologics are large, complex molecules derived from living organisms, while small molecules are chemically synthesized. Both types of drugs are used to treat autoimmune diseases, but biologics are more effective and have fewer side effects. The Autoimmune Disease Drug market is highly competitive, with many companies developing and marketing drugs for the treatment of autoimmune diseases. Some of the major players in the market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, and Roche. Show Less Read more